|
ZNF761 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.104200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.071640E-02 |
| Normal-vs-Stage2 |
2.142100E-02 |
| Normal-vs-Stage3 |
2.295400E-01 |
| Normal-vs-Stage4 |
1.338790E-01 |
| Stage1-vs-Stage2 |
2.799800E-01 |
| Stage1-vs-Stage3 |
6.086200E-01 |
| Stage1-vs-Stage4 |
8.102200E-01 |
| Stage2-vs-Stage3 |
2.486400E-01 |
| Stage2-vs-Stage4 |
3.003400E-01 |
| Stage3-vs-Stage4 |
8.209600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.364600E-03 |
| Normal-vs-AfricanAmerican |
5.827000E-01 |
| Normal-vs-Asian |
2.524200E-01 |
| Caucasian-vs-AfricanAmerican |
1.863350E-01 |
| Caucasian-vs-Asian |
5.371400E-01 |
| AfricanAmerican-vs-Asian |
2.124400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.504600E-03 |
| Normal-vs-Female |
3.219600E-02 |
| Male-vs-Female |
6.387200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.317200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.444700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.499500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.284600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.255400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.568600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.382020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.304600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.125500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.602590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.792400E-02 |
| Normal-vs-Grade 2 |
3.704900E-03 |
| Normal-vs-Grade 3 |
1.518780E-01 |
| Normal-vs-Grade 4 |
3.138000E-01 |
| Grade 1-vs-Grade 2 |
5.500800E-01 |
| Grade 1-vs-Grade 3 |
2.287800E-01 |
| Grade 1-vs-Grade 4 |
2.553600E-01 |
| Grade 2-vs-Grade 3 |
1.517220E-01 |
| Grade 2-vs-Grade 4 |
3.153000E-01 |
| Grade 3-vs-Grade 4 |
9.949200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.631500E-02 |
| Normal-vs-ccB subtype |
9.366100E-04 |
| ccA subtype-vs-ccB subtype |
4.322200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.075300E-03 |
| Normal-vs-N1 |
8.375000E-01 |
| N0-vs-N1 |
5.210800E-01 |
|
|
